BiomACS (Biomaterial Advanced Cell Screening) specializes in improving the interaction between the human body and implants. With our unique screening technology, we can quickly and accurately test how human cells respond to different materials, a process that traditionally takes years, but with us only takes a few days. Our expertise lies at the intersection of materials science, chemistry, cell biology, and clinical practice. Thanks to this multidisciplinary approach, we support the medical industry in developing safer, higher-performing, and more personalized medical devices.
BiomACS provides screening services for manufacturers of implants such as prostheses, stents, catheters, and intraocular lenses. Our technology helps them achieve better designs faster and reduce complications such as rejection or infection. In this way, we contribute to a higher quality of life for patients worldwide. (www.biomacs.nl)
